Biologic lung volume reduction therapy for advanced homogeneous emphysema

The European Respiratory Journal
Yael RefaelyGerard Criner

Abstract

This report summarises phase 2 trial results of biologic lung volume reduction (BioLVR) for treatment of advanced homogeneous emphysema. BioLVR therapy was administered bronchoscopically to 25 patients with homogeneous emphysema in an open-labelled study. Eight patients received low dose (LD) treatment with 10 mL per site at eight subsegments; 17 received high dose (HD) treatment with 20 mL per site at eight subsegments. Safety was assessed in terms of medical complications during 6-month follow-up. Efficacy was assessed in terms of change from baseline in gas trapping, spirometry, diffusing capacity, exercise capacity, dyspnoea and health-related quality of life. There were no deaths or serious medical complications during the study. A statistically significant reduction in gas trapping was observed at 3-month follow-up among HD patients, but not LD patients. At 6 months, changes from baseline in forced expiratory volume in 1 s (-8.0+/-13.93% versus +13.8+/-20.26%), forced vital capacity (-3.9+/-9.41% versus +9.0+/-13.01%), residual volume/total lung capacity ratio (-1.4+/-13.82% versus -5.4+/-12.14%), dyspnoea scores (-0.4+/-1.27 versus -0.8+/-0.73 units) and St George's Respiratory Questionnaire total domain scores (-4.9+/-8...Continue Reading

Citations

Jul 14, 2010·American Journal of Respiratory and Critical Care Medicine·Michael J EmeryErik R Swenson
Jul 2, 2011·American Journal of Respiratory and Critical Care Medicine·Gerard J CrinerFernando J Martinez
May 29, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Imran H IftikharAli I Musani
Jul 9, 2011·Pulmonary Medicine·Armin Ernst, Devanand Anantham
Sep 3, 2013·Clinics in Chest Medicine·Michael J SimoffRabih I Bechara
Jan 1, 2010·Seminars in Thoracic and Cardiovascular Surgery·Armin Ernst, Devanand Anantham
Apr 23, 2011·Clinics in Chest Medicine·Gerard J Criner
Jan 15, 2015·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Anna AndrychiewiczWojciech Szczeklik
Dec 1, 2010·Respiratory Medicine·Oren FruchterMordechai R Kramer
Aug 11, 2012·Therapeutic Advances in Respiratory Disease·Pyng Lee, Kay Leong Khoo
Feb 24, 2017·The Cochrane Database of Systematic Reviews·Joseph Em van AgterenBrian J Smith
Sep 2, 2015·The European Respiratory Journal·Erik Folch, Gunnar Hillerdal
May 31, 2019·Journal of Thoracic Imaging·Alexander S RabinErik E Folch
Dec 11, 2013·Current Opinion in Anaesthesiology·Edmond Cohen
Dec 25, 2013·Annals of the American Thoracic Society·Hans J LeeDaniel H Sterman
Oct 20, 2011·Journal of Thoracic Imaging·Armin Ernst, Devanand Anantham
Jan 15, 2013·Current Opinion in Pulmonary Medicine·Amit Taneja
Sep 2, 2020·Expert Review of Respiratory Medicine·Paul ZarogoulidisLutz Freitag
Jan 31, 2012·Expert Review of Respiratory Medicine·Nicolino Ambrosino, Pierluigi Paggiaro
Apr 5, 2017·Case Reports in Medicine·Yihenew Negatu, Philip T Diaz
Dec 25, 2013·Annals of the American Thoracic Society·Daniela GompelmannFelix J F Herth
Dec 23, 2011·Southern Medical Journal·Sherry L TidwellMark T Dransfield
Nov 2, 2016·The Cochrane Database of Systematic Reviews·Joseph Em van AgterenBrian J Smith
Sep 25, 2020·International Journal of Molecular Sciences·Molly EasterStefanie Krick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved